Valladolid
Universidad
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoGlaxoSmithKline (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (12)
2022
-
Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain
PharmacoEconomics - Open, Vol. 6, Núm. 4, pp. 509-518
-
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
European Respiratory Journal, Vol. 59, Núm. 2
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation
American Journal of Respiratory and Critical Care Medicine, Vol. 203, Núm. 1, pp. 37-53
2019
-
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
European Respiratory Journal
-
IL-17–high asthma with features of a psoriasis immunophenotype
Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 5, pp. 1198-1213
2018
-
A computational framework for complex disease stratification from multiple large-scale datasets
BMC Systems Biology, Vol. 12, Núm. 1
-
Bioelectronic modulation of carotid sinus nerve activity in the rat: a potential therapeutic approach for type 2 diabetes
Diabetologia, Vol. 61, Núm. 3, pp. 700-710
2017
-
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
Journal of Allergy and Clinical Immunology, Vol. 139, Núm. 6, pp. 1797-1807
1987
-
THE ADRENAL-MEDULLA AS A MODEL TO STUDY SHORT-TERM AND LONG-TERM PLASTICITY OF COSECRETION OF MULTIPLE CHEMICAL MESSENGERS
ACTA PHYSIOLOGICA ET PHARMACOLOGICA LATINOAMERICANA